NCAA Men’s Basketball Standout Shines a Light on Cancer Risk Factors
Cancer Treatment Centers of America® (CTCA) is proud to join forces with college basketball star Kofi Cockburn to spread awareness about cancer risk factors, the importance of routine screening, prevention and early detection. Cockburn, a University of Illinois men’s basketball player and newly named 2022 First Team All-American by the Associated Press, will take to social media with a goal to turn cancer prevention advocacy into action, highlighted by the CTCA® Risk Management Tool.
Considering the staggering statistics that one in two men and one in three women will develop cancer in their lifetime and that 42% of cancer cases diagnosed in the U.S. are potentially preventable through lifestyle changes and/or regular screenings, CTCA developed its Risk Management Tool to provide immediate access to personalized cancer information and key prevention strategies. The free online assessment allows individuals to gauge their risk for over seven of the most common cancer types through a single, easy-to-use questionnaire. Results are personalized based on the user’s medical history, providing critical education on the most up-to-date clinical guidance and empowering users to manage their risk for cancer or a late-stage diagnosis. Recommendations developed by a cross-functional clinical team include screening protocols, genetic counseling, lifestyle changes and advanced prevention.
Cockburn, whose father died of a heart attack at age 61 in 2015, understands the importance of knowing your family history and taking control of your health. Like his success on the basketball court, he believes in the value of a playbook when it comes to a healthy lifestyle. A playbook for cancer prevention means a personalized action plan with evidence-based screening and lifestyle recommendations.
About Cancer Treatment Centers of America
Cancer Treatment Centers of America (CTCA), part of City of Hope, is a national network of oncology hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA publishes treatment results biannually, including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.
City of Hope’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. As an independent, National Cancer Institute (NCI)-designated comprehensive cancer center, City of Hope reflects a uniquely integrated model spanning cancer care, research and development, academics and training, and innovation initiatives. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram, or LinkedIn.